anti-VCAM-1-tTF VTA (Peregrine (Techniclone))

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameanti-VCAM-1-tTF VTA (Peregrine (Techniclone))

Drug Alias Namevascular targeting agent VCAM-1 (Peregrine (Techniclone))

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionTissue factor modulatorsVascular cell adhesion molecule 1 inhibitors

TargetsVascular cell adhesion molecule 1Tissue factor

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAvid Bioservices Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAvid Bioservices Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A